A Platform Technology

NovaScan’s AI-enhanced biospectral impedance technology is a true platform, supporting multiple diagnostic and intraoperative oncology applications built on a shared hardware, software, and data foundation.

Several of these products have already been prototyped and evaluated in clinical trials.